Abstract
The prognosis for idiopathic pulmonary fibrosis (IPF) is very poor, with a median survival of 2 to 4 years after the diagnosis, yet the disease course in individual patients is highly variable. Predicting prognosis in individual patients is challenging, but various clinical and radiologic variables have been identified. Although postoperative morbidity and mortality rates in patients with lung cancer have decreased with advances in perioperative management, those patients with IPF remain at a high risk for complications and death.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
